A Randomized Phase 3 Single Blind Study of Temozolomide Plus Radiation Therapy Combined With Nivolumab or Placebo in Newly Diagnosed Adult Subjects With MGMT-Methylated (Tumor O6-methylguanine DNA Methyltransferase) Glioblastoma
收藏DataCite Commons2026-01-29 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012712/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate patients with glioblastoma that is MGMT-methylated (the MGMT gene is altered by a chemical change). Patients will receive temozolomide plus radiation therapy. They will be compared to patients receiving nivolumab in addition to temozolomide plus radiation therapy.
提供机构：
Vivli
创建时间：
2026-01-29
